Medium Image
607
page-template,page-template-blog-small-image,page-template-blog-small-image-php,page,page-id-607,page-child,parent-pageid-1815,strata-core-1.1.1,strata-theme-ver-3.4,ajax_fade,page_not_loaded,wpb-js-composer js-comp-ver-6.7.0,vc_responsive,elementor-default,elementor-kit-

Medium Image

Sed ut perspiciatis unde omnis

First Treatment for ASMD approved by FDA

04 September in News

The US FDA has announced approving Xenpozyme (Olipudase alfa), for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase Deficiency (ASMD). The medication is the first to treat symptoms that are not related to the central nervous system in patients with ASMD. ASMD is...